CompletedInterventional

A Phase 1 trial: Fortrea Phase 1 Leeds Clinic: SUDO-550-101

This is an early-stage medical study, known as a Phase 1 trial, called Fortrea Phase 1 Leeds Clinic: SUDO-550-101. It's happening at a clinic in Leeds. At the moment, we don't have many details about what this study is exploring or what treatments, if any, are involved. This is because the organisation that oversees health research, the Health Research Authority (HRA), has allowed the researchers to delay sharing the full details publicly. This means that information about the study's purpose, what participants will do, and who is eligible to take part will be made available within 30 months after the study has officially ended. Both men and women of any age can potentially be considered for this type of research.

At a glance

Status

Completed

Sponsor

Sudo Biosciences Limited

Enrolment target

165

Start

03 Oct 2024

Estimated completion

20 Aug 2025

The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

What is this study about?

This study, named Fortrea Phase 1 Leeds Clinic: SUDO-550-101, is an early-stage clinical trial, often called a 'Phase 1' study. These studies are usually the first step in testing a new treatment or medicine in people. Their main goal is often to check if a new treatment is safe and to find the right dose. They don't usually aim to cure a disease at this early stage, but rather to gather important basic information.

At this time, we don't have all the specific details about what this study is investigating. This is because the Health Research Authority (HRA), which makes sure health research is ethical and transparent, has given permission for the full information about the study to be shared later. This is sometimes done to protect new ideas or research methods until the study is further along.

Rest assured, the full and complete information about this study will eventually be made public. This will happen within 30 months after the study has finished. Once that time comes, you'll be able to find all the details about what the study was for, what happened, and what was learned.

Key takeaways

This is an early-stage (Phase 1) medical study in Leeds.
Full details about the study are not yet public.
Information will be released within 30 months after the study finishes.
It aims to test new treatments for safety and dosage.
Open to both men and women, potentially of all ages.

Who may be eligible?

Currently, the specific rules for who can and cannot join this study haven't been made public. This means we don't know the exact health conditions, age restrictions (other than that both adults and children could potentially be eligible), or other requirements for taking part.

What we do know is that the study is open to both men and women. The age range is listed as 'any to any', which suggests that people of all ages might be considered, but this will depend on the unreleased specific criteria.

You will need to wait until the full study details are released within 30 months after the study ends to understand the exact eligibility requirements. If you were interested in joining, you would need to meet all the inclusion criteria and none of the exclusion criteria.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Am I male or female?
Am I willing to potentially be considered if I am of any age?
Am I available for potential visits to the Fortrea Phase 1 Leeds Clinic?
Am I open to participating in a study where the full details are not yet public?
Do I understand that I would need to meet future undisclosed criteria?

Answer every question to see your result.

What does participation involve?

Because the full details of this study are not yet available, we cannot provide specific information about what taking part would involve. Generally, in a Phase 1 study, participants might:

* **Have multiple visits:** These could involve stays at the clinic, sometimes overnight, or regular outpatient appointments. * **Undergo various assessments:** This might include blood tests, urine tests, physical examinations, heart checks (like ECGs), and other scans or tests to make sure you are healthy enough to participate and to monitor any effects of the treatment. * **Receive a study medication:** This is typically given in a controlled way, often under medical supervision. The dose might be gradually increased over time for different groups of participants. * **Have follow-up appointments:** Even after you stop receiving the treatment, you might have follow-up visits to check your health.

The total duration of participating in such a study can vary greatly, from a few days or weeks to several months, depending on the specific study design. All these details will be clearly explained once the full study information is made public.

Potential risks and benefits

Since the full details of this study are not yet available, we can't tell you the specific potential benefits or risks for this particular trial. Generally, in early-stage studies like this, the direct personal benefits to participants are often small, as the main goal is to gather information about a new treatment. However, you would be helping to advance medical knowledge, which could benefit others in the future. As with any medical study, there can be risks, including side effects from the treatment or discomfort from the tests and procedures. It's very important to remember that you always have the right to withdraw from a study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Fortrea Clinical Research Unit Limited
City only
Leeds, United Kingdom

Common questions

What is a 'Phase 1' trial?

A Phase 1 trial is one of the first human tests of a new medicine or treatment. It usually checks if the treatment is safe and helps find the right dose, rather than curing a disease.

Why can't I see all the study details now?

The Health Research Authority (HRA) has allowed the researchers to delay sharing some details. This is occasionally done to protect new research ideas before they are fully public. All information will be released eventually.

When will the full study details be available?

The full details will be put onto the study record within 30 months after the study has officially ended.

Who can take part in this study?

The study is for both men and women, and potentially people of any age. However, the specific rules about who can join haven't yet been released.

Where is this study taking place?

This study is taking place at the Fortrea Phase 1 Leeds Clinic in Leeds.

How to find out more

Ian Mills

IMills@sudobio.com None provided Official trial record

Always speak to your GP or specialist before deciding to take part in a study.